| Axitinib studied in …STUDIED_INderived160 of 160show fewer |
|---|
| → studied in | NCT04693468Phase 1 · recruiting Talazoparib and Palbociclib, Axitinib, or Crizotinib for the Treatment of Advanced or Metastatic Solid Tumors, TalaCom Trial · 160 trials list this drug (35 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05327686Phase 2 · recruiting Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial · 160 trials list this drug (35 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07227415Phase 1/Phase 2 · recruiting Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer · 160 trials list this drug (35 active) | — | — | Carcinoma,Kidney Neoplasm,Clear Cell Renal Cell Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07816770Phase 2 · not yet recruiting MANTIS-RCC: Toripalimab-Axitinib Induction in TLS-Positive Advanced Non-Clear Cell and Renal Medullary Carcinomas · 160 trials list this drug (35 active) | — | — | Non-Clear Cell Renal Cell Carcinoma,Renal Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03595124Phase 2 · active not recruiting A Study to Compare Treatments for a Type of Kidney Cancer Called TFE/Translocation Renal Cell Carcinoma (tRCC) · 160 trials list this drug (35 active) | — | — | Renal Cell Carcinoma,TFE3-Rearranged Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07123090Phase 2 · recruiting A Study of Sasanlimab, Palbociclib and Axitinib in Metastatic Renal Cell Carcinoma · 160 trials list this drug (35 active) | — | — | Malignant Kidney Neoplasm,Clear Cell Renal Cell Carcinoma,Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07776717Phase 2 · not yet recruiting TACTIC-RCC: Toripalimab Plus Axitinib Induction With Selective Deferred Cytoreductive Nephrectomy in TLS-Positive Advanced Clear Cell Renal Cell Carcinoma · 160 trials list this drug (35 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05805501Phase 2 · active not recruiting A Study of Immune Checkpoint Inhibitor Combinations With Axitinib in Participants With Untreated Locally Advanced Unresectable or Metastatic Renal Cell Carcinoma · 160 trials list this drug (35 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04996823Phase 2 · active not recruiting Axitinib + Ipilimumab in Advanced Melanoma · 160 trials list this drug (35 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02912572Phase 2 · active not recruiting Avelumab in Patients With MSS, MSI-H and POLE-mutated Recurrent or Persistent Endometrial Cancer and of Avelumab/Talazoparib and Avelumab/Axitinib in Patients With MSS Recurrent or Persistent Endometrial Cancer · 160 trials list this drug (35 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05256472Phase 2 · completed A Study of AK104 Monotherapy or AK104 Plus Axitinib in Advanced/Metastatic Renal Cell Carcinoma · 160 trials list this drug (35 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05059522Phase 3 · active not recruiting Continued Access Study for Participants Deriving Benefit in Pfizer-Sponsored Avelumab Parent Studies That Are Closing · 160 trials list this drug (35 active) | — | — | Solid Neoplasm,Lung Non-Small Cell Carcinoma,Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07383441Phase 3 · recruiting Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer · 160 trials list this drug (35 active) | — | — | Clear Cell Renal Cell Carcinoma,Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05017012Phase 1 · completed A Study to Evaluate the Bioavailability of Pembrolizumab (MK-3475) Via Subcutaneous (SC) Injection of Pembrolizumab Formulated With Berahyaluronidase Alfa (MK-5180) [MK-3475A] In Advanced Solid Tumors (MK-3475A-C18) · 160 trials list this drug (35 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07630363Phase 1/Phase 2 · not yet recruiting PTC-Guided Atorvastatin Plus Axitinib and Toripalimab in Advanced RCC · 160 trials list this drug (35 active) | — | — | Renal Cell Carcinoma,Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04458259Phase 1 · terminated Study of PF-07265807 in Participants With Metastatic Solid Tumors. · 160 trials list this drug (35 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05949632Phase 1/Phase 2 · terminated A Study of INCB099280 in Combination With Axitinib in Adults With Advanced Solid Tumors · 160 trials list this drug (35 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03092856Phase 2 · active not recruiting Axitinib With or Without Anti-OX40 Antibody PF-04518600 in Treating Patients With Metastatic Kidney Cancer · 160 trials list this drug (35 active) | — | — | Clear Cell Renal Cell Carcinoma,Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03172754Phase 1/Phase 2 · active not recruiting Study of Nivolumab and Axitinib in Patients With Advanced Renal Cell Carcinoma · 160 trials list this drug (35 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04640545Phase 1 · completed A Study to Assess LBL-007 in Combination With Toripalimab and Axitinib Tablets Subjects With Advanced Melanoma · 160 trials list this drug (35 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02535533Phase 1/Phase 2 · completed SLM + Axitinib for Clear Cell RCC · 160 trials list this drug (35 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01744249Phase 2/Phase 3 · completed Sandostatin LAR and Axitinib vs Pbo in Pnts With Advanced Well-differentiated Non-pancreatic Neuroendocrine Carcinomas · 160 trials list this drug (35 active) | — | — | Malignant Neoplasm,Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04355156Phase 2 · completed Axitinib Monotherapy With Early Dynamic Contrast Enhanced Ultrasound Monitoring in Chemorefractory Third Line Metastatic Colorectal Cancer · 160 trials list this drug (35 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05969496Phase 2 · recruiting Neoadjuvant Pembrolizumab and Axitinib in Renal Cell Carcinoma With Inferior Vena Cava Tumor Thrombus · 160 trials list this drug (35 active) | — | — | Kidney Neoplasm,Malignant Kidney Neoplasm,Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05808608Phase 1/Phase 2 · active not recruiting A Study of AK104 Plus Axitinib in Advanced/Metastatic Special Pathological Subtypes of Renal Cell Carcinoma · 160 trials list this drug (35 active) | — | — | Sarcomatoid Renal Cell Carcinoma,Renal Cell Carcinoma,Non-Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07500831NA · not yet recruiting Fasting-Mimicking Diet Combined With IO-TKI Combination Therapy in Patients With Metastatic Renal Cell Carcinoma · 160 trials list this drug (35 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03297606Phase 2 · recruiting Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR) · 160 trials list this drug (35 active) | — | — | Solid Neoplasm,Multiple Myeloma,Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07469683Phase 2 · recruiting An Open-label, Randomized Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of the Combination Therapy of SLC-3010 and Axitinib Compared to Axitinib Monotherapy as a Second-line Treatment for Locally Advanced or Metastatic Clear Cell Renal Cell Carcinoma · 160 trials list this drug (35 active) | — | — | Neoplasm,Malignant Neoplasm,Clear Cell Renal Cell Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06860386Phase 2 · suspended Study of Adaptive Immunotherapy With VEGFR-TKI in Patients With Advanced RCC · 160 trials list this drug (35 active) | — | — | Clear Cell Renal Cell Carcinoma,Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01409200Phase 2 · completed Antiandrogen Therapy With or Without Axitinib Before Surgery in Treating Patients With Previously Untreated Prostate Cancer With Known or Suspected Lymph Node Metastasis · 160 trials list this drug (35 active) | — | — | Prostate Adenocarcinoma,Prostate Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03839498Phase 2 · active not recruiting Study of Axitinib (AG-013736) With Evaluation of the VEGF-pathway in Pheochromocytoma/Paraganglioma · 160 trials list this drug (35 active) | — | — | Paraganglioma,Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05384496Phase 2 · recruiting Axitinib and Nivolumab for the Treatment of Mucosal Melanoma · 160 trials list this drug (35 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02853331Phase 3 · completed Study to Evaluate the Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Axitinib Versus Sunitinib Monotherapy in Participants With Renal Cell Carcinoma (MK-3475-426/KEYNOTE-426) · 160 trials list this drug (35 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04585815Phase 1/Phase 2 · terminated Study of Immunotherapy (Sasanlimab) in Combination With Targeted Therapies in People With Advanced Non-small Cell Lung Cancer (NSCLC) (Landscape 1011 Study) · 160 trials list this drug (35 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05363631Phase 1/Phase 2 · active not recruiting Seleno-L Methionine (SLM)-Axitinib-Pembrolizumab · 160 trials list this drug (35 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04370509Phase 2 · terminated Pembrolizumab With or Without Axitinib for Clear Cell Kidney Cancer in Patients Undergoing Surgery · 160 trials list this drug (35 active) | — | — | Clear Cell Renal Cell Carcinoma,Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06962787Phase 2 · recruiting A Study of BL-B01D1+TKI±Pembrolizumab in Patients With Locally Advanced or Metastatic Renal Cancer · 160 trials list this drug (35 active) | — | — | Kidney Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03438708Phase 2 · active not recruiting Prior Axitinib as a Determinant of Outcome of Renal Surgery · 160 trials list this drug (35 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04258956Phase 2 · completed A Study of Avelumab In Combination With Axitinib in Patients With Unresectable/Metastatic Gastrointestinal Stromal Tumor After Failure of Standard Therapy · 160 trials list this drug (35 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02684006Phase 3 · completed A Study of Avelumab With Axitinib Versus Sunitinib In Advanced Renal Cell Cancer (JAVELIN Renal 101) · 160 trials list this drug (35 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04341181Phase 2 · recruiting ProTarget - A Danish Nationwide Clinical Trial on Targeted Cancer Treatment Based on Genomic Profiling · 160 trials list this drug (35 active) | — | — | Neoplasm,Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04522323Phase 1 · active not recruiting A Study to Evaluate MEDI5752 and Axitinib in Subjects With Advanced Renal Cell Carcinoma · 160 trials list this drug (35 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06161558Phase 1 · withdrawn Erlotinib in Combination With Select Tyrosine Kinase Inhibitors in Adult Patients With Advanced Solid Tumors · 160 trials list this drug (35 active) | — | — | Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04493203Phase 2 · completed Nivolumab Plus Axitinib in Patients With Anti-PD1 Refractory Advanced Melanoma · 160 trials list this drug (35 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03826589NA · completed Avelumab With Axitinib in Persistent or Recurrent Cervical Cancer After Platinum-based Chemotherapy · 160 trials list this drug (35 active) | — | — | Malignant Cervical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04337970Phase 1/Phase 2 · completed Talazoparib and Axitinib for People With Previously Treated Advanced Kidney Cancer · 160 trials list this drug (35 active) | — | — | Malignant Kidney Neoplasm,Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02597322Phase 2 · completed Study of Axitinib for Downstaging Large Renal Tumors Not Primarily Suitable for Partial Nephrectomy (AXIPAN) · 160 trials list this drug (35 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05650164completed Treatment Outcomes in Japanese RCC Patients Treated With Avelumab Plus Axitinib as First-line Therapy: Retrospective Study (J-DART2) · 160 trials list this drug (35 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06889649Phase 2 · recruiting SABR Combined with Axitinib and Toripalimab in Recurrent or Metastatic RCC · 160 trials list this drug (35 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06364631Phase 3 · recruiting CARE1 Pragmatic Clinical Trial · 160 trials list this drug (35 active) | — | — | Malignant Kidney Neoplasm,Kidney Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04562441Phase 2 · completed NPC - AXEL Study : Axitinib-Avelumab · 160 trials list this drug (35 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05097599Phase 2 · terminated StrataPATH™ (Precision Indications for Approved Therapies) · 160 trials list this drug (35 active) | — | — | Malignant Neoplasm,Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04682587completed To Examine the Effects of Axitinib Dose Reduction and Interruption for Adverse Event Management Among Patients Receiving Axitinib in for the Treatment of Advanced Renal Cell Carcinoma · 160 trials list this drug (35 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05941637no longer available An Expanded Access Program to Axitinib is Available for Patients With Advanced Forms of Kidney Cancer (Ductal; Papillary; Chromophobic; Oncocytic) With Mutations in VHL, PBRM1 / BAP1, SETD2, VEGF) · 160 trials list this drug (35 active) | — | — | Malignant Kidney Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05904730Phase 1 · completed Phase I Clinical Trials Investigating the Potential Efficacy of Axitinib in Patients With a BRCA 1/2 Mutations · 160 trials list this drug (35 active) | — | — | Breast Neoplasm,Malignant Breast Neoplasm,Ovarian Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00828919NA · completed Continuing Access to Axitinib (A406- AG- 013736 ) For Patients Previously Receiving AG 013736 In Clinical Trials · 160 trials list this drug (35 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06211114Phase 2 · recruiting Study to Evaluate the Efficacy and Safety of Immunotherapy With Axitinib in Advanced Collecting Duct Carcinoma · 160 trials list this drug (35 active) | — | — | Collecting Duct Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01693822Phase 2 · completed A Phase II Study of Axitinib in Patients With Metastatic Renal Cell Cancer Unsuitable for Nephrectomy · 160 trials list this drug (35 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02639182Phase 2 · completed A Study of AGS-16C3F vs. Axitinib in Metastatic Renal Cell Carcinoma · 160 trials list this drug (35 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06690697Phase 2 · recruiting Combination of Toripalimab and JS004 Therapy for ccRCC · 160 trials list this drug (35 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03990571Phase 2 · completed Axitinib and Avelumab in Treating Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma · 160 trials list this drug (35 active) | — | — | Adenoid Cystic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02667886Phase 1/Phase 2 · completed Trial of X4P-001 in Participants With Advanced Renal Cell Carcinoma · 160 trials list this drug (35 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00700258completed Registry For Temsirolimus, Sunitinib, And Axitinib Treated Patients With Metastatic Renal Cell Carcinoma (mRCC), Mantle Cell Lymphoma (MCL), And Gastro-Intestinal Stroma Tumor (GIST) [STAR-TOR] · 160 trials list this drug (35 active) | — | — | Carcinoma,Mantle Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01263769Phase 2 · completed Neoadjuvant Axitinib in Locally Advanced Renal Cell Carcinoma (RCC) · 160 trials list this drug (35 active) | — | — | Malignant Kidney Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04669366completed Treatment Patterns With Targeted Therapies In Mrcc In Sweden - A Retrospective Analysis Of Data From National Registries · 160 trials list this drug (35 active) | — | — | Kidney Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02636725Phase 2 · completed Axitinib and Pembrolizumab in Subjects With Advanced Alveolar Soft Part Sarcoma and Other Soft Tissue Sarcomas · 160 trials list this drug (35 active) | — | — | Soft Tissue Sarcoma,Alveolar Soft Part Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02859012Phase 2 · completed Study of Axitinib in Patients With Recurred or Metastatic Adenoid Cystic Carcinoma · 160 trials list this drug (35 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04873895Phase 1 · terminated TACE Plus Axitinib and Hydroxychlorquine for Liver-Dominant Metastatic Colorectal Cancer (CRC) · 160 trials list this drug (35 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03472560Phase 2 · terminated A Study of Avelumab in Combination With Axitinib In Non-Small Cell Lung Cancer (NSCLC) or Urothelial Cancer (Javelin Medley VEGF) · 160 trials list this drug (35 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02156895completed Post Marketing Surveillance Study to Observe Safety and Efficacy of Inlyta in South Korea · 160 trials list this drug (35 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04540705Phase 1 · completed A Study to Compare Bempegaldesleukin (BEMPEG: NKTR-214) Combined With Nivolumab and Tyrosine Kinase Inhibitor (TKI) to Nivolumab and TKI Alone in Participants With Previously Untreated Kidney Cancer That is Advanced or Has Spread · 160 trials list this drug (35 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06279403Phase 2 · not yet recruiting Upfront Immune Checkpoint Inhibitors With Deferred Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma · 160 trials list this drug (35 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05096390Phase 2 · unknown Axitinib +/- Pembrolizumab in First Line Treatment of mPRCC · 160 trials list this drug (35 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02925234Phase 2 · recruiting The Drug Rediscovery Protocol (DRUP Trial) · 160 trials list this drug (35 active) | — | — | Neoplasm,Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03386929Phase 1/Phase 2 · terminated Survival Prolongation by Rationale Innovative Genomics · 160 trials list this drug (35 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05012865completed Current Treatment Outcomes in Japanese RCC Patients Treated With Avelumab Plus Axitinib as First-line Therapy: Retrospective Study (J-DART) · 160 trials list this drug (35 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05394493completed An Observational Chart Review Study To Describe The Real-World Outcomes And Use Of Avelumab In Combination With Axitinib For Treatment Of Patients With aRCC In The UK · 160 trials list this drug (35 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04555603withdrawn Axitinib Therapy Management Study · 160 trials list this drug (35 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05176288Phase 2 · withdrawn Avelumab, Palbociclib and Axitinib in Advanced RCC · 160 trials list this drug (35 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02579811Phase 2 · completed Axitinib Given on an Individualized Schedule for Metastatic Renal Cell Cancer · 160 trials list this drug (35 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05817903Phase 2 · recruiting Axitinib Intensification Plus Nivolumab or Nivolumab Alone After Nivolumab Plus Ipilimumab in mRCC Patients · 160 trials list this drug (35 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05249569Phase 2 · terminated Study of Bavituximab, Axitinib, and Avelumab in Advanced Hepatocellular Carcinoma · 160 trials list this drug (35 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04033991completed Study of Patients With Metastatic and/or Advanced Renal Cell Carcinoma, Treated With Sunitinib/Axitinib. · 160 trials list this drug (35 active) | — | — | Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04118855Phase 2 · completed Toripalimab Combined With Axitinib as Neoadjuvant Therapy in Patients With Non-metastatic Locally Advanced Nonmetastatic Clear Cell Renal Cell Carcinoma · 160 trials list this drug (35 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05768464Phase 2 · recruiting Postoperative Adjuvant Therapy for Non-clear Renal Cell Carcinoma With High-risk Recurrence Factors · 160 trials list this drug (35 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01385059Phase 2 · completed Axitinib Before Surgery in Treating Patients With High-Risk Prostate Cancer · 160 trials list this drug (35 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02489695Phase 2 · completed Axitinib in1st Line Treatment for Patients With Advanced or Metastatic Papillary Renal Cell Carcinoma · 160 trials list this drug (35 active) | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05263609Phase 2 · withdrawn Optimizing Pembrolizumab Therapy With Timing and Intensification With Axitinib · 160 trials list this drug (35 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00920816Phase 3 · completed Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer · 160 trials list this drug (35 active) | — | — | Kidney Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02493751Phase 1 · completed A Study Of Avelumab In Combination With Axitinib In Advanced Renal Cell Cancer (JAVELIN Renal 100) · 160 trials list this drug (35 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02129647Phase 2 · completed Study of Axitinib in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas · 160 trials list this drug (35 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05070221Phase 1 · unknown Study of Oncolytic Virus in Combination With HX-008 and Axitinib in Melanoma Patients With Liver Metastasis · 160 trials list this drug (35 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02261207Phase 2 · completed Phase II Study on Axitinib in Advanced Solitary Fibrous Tumor · 160 trials list this drug (35 active) | — | — | Solitary Fibrous Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01649180Phase 2 · terminated NEXT: Subsequent Exposure to Tyrosine Kinase Inhibition at Recurrence After Adjuvant Therapy in Renal Cell Carcinoma · 160 trials list this drug (35 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04995016Phase 2 · unknown Pembrolizumab and Axitinib as Neoadjuvant Therapy for Locally Advanced Non-metastatic Clear Cell Renal Cell Carcinoma · 160 trials list this drug (35 active) | — | — | Clear Cell Renal Cell Carcinoma,Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02133742Phase 1 · completed A Dose Finding Study To Evaluate Safety, Drug Interaction, Tumor Markers Of Axitinib In Combination With MK-3475 In Adult Patients With Previously Untreated Advanced Renal Cell Cancer · 160 trials list this drug (35 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04958473Phase 2 · unknown A Study of Sintilimab in Combination With Axitinib in Advanced Renal Cell Cancer · 160 trials list this drug (35 active) | — | — | Clear Cell Renal Cell Carcinoma,Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03494816Phase 2 · completed Study of Axitinib for Reducing Extent of Venous Tumour Thrombus in Renal Cancer With Venous Invasion · 160 trials list this drug (35 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02762513Phase 2 · completed Expansion Trial for Axitinib In Head And Neck Cancer · 160 trials list this drug (35 active) | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01140737Phase 2 · completed A Study of Axitinib in Patients With Advanced Angiosarcoma and Other Soft Tissue Sarcomas · 160 trials list this drug (35 active) | — | — | Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02354612no longer available Open Label Continuation Study of TRC105 for Patients Who Have Completed a Prior TRC105 Trial · 160 trials list this drug (35 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04637204completed Real-world Treatment Patterns and Outcomes Among aRCC Patients on Cabozantinib or Axitinib in England · 160 trials list this drug (35 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01321437Phase 2 · completed Study of the Anti-Angiogenesis Agent Axitinib in Patients With Stage III Malignant Melanoma · 160 trials list this drug (35 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01967576Phase 2 · completed Phase II Study of Axitinib (AG-013736) With Evaluation of the VEGF-pathway in Metastatic, Recurrent or Primary Unresectable Pheochromocytoma/Paraganglioma · 160 trials list this drug (35 active) | — | — | Paraganglioma,Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04698213Phase 2 · unknown Avelumab Plus Intermittent Axitinib in Previously Untreated Patients With Metastatic Renal Cell Carcinoma · 160 trials list this drug (35 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01798446Phase 2 · completed A Phase II Study of Axitinib in Metastatic Non-clear Cell Renal Cell Carcinoma Patients Previously Treated With Temsirolimus · 160 trials list this drug (35 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02782403Phase 1 · terminated Axitinib and Bosutinib in Treating Patients With Chronic, Accelerated, or Blastic Phase Chronic Myeloid Leukemia · 160 trials list this drug (35 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive,Accelerated Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive,Blast Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04197219Phase 2 · withdrawn Pembrolizumab With Axitinib in Recurrent Endometrial Cancer · 160 trials list this drug (35 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01806064Phase 1/Phase 2 · terminated Randomized Phase 2 Trial of Axitinib and TRC105 Versus Axitinib Alone in Patients Renal Cell Carcinoma · 160 trials list this drug (35 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01999972Phase 1 · completed A Phase 1b Study Of Axitinib In Combination With Crizotinib In Patients With Advanced Solid Tumors · 160 trials list this drug (35 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03289533Phase 1 · completed A Study Of Avelumab In Combination With Axitinib In Advanced HCC (VEGF Liver 100) · 160 trials list this drug (35 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04385654Phase 2 · unknown Toripalimab Combined With Axitinib as Neoadjuvant Therapy for Advanced/Metastatic Non-clear Cell Renal Cell Carcinoma · 160 trials list this drug (35 active) | — | — | Malignant Neoplasm,Malignant Kidney Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02638428Phase 2 · unknown Genomics-Based Target Therapy for Children With Relapsed or Refractory Malignancy · 160 trials list this drug (35 active) | — | — | Childhood Solid Neoplasm,Childhood Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01334112Phase 2 · completed Study of Axitinib in Patients With Unresectable Hepatocellular Carcinoma · 160 trials list this drug (35 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03941795Phase 2 · unknown Phase II Study in the Treatment of Patients With Advanced Mucinous Melanoma · 160 trials list this drug (35 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00859118Phase 1 · completed Pharmacodynamic Study of Axitinib in Patients With Advanced Solid Malignancies · 160 trials list this drug (35 active) | — | — | Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01540526Phase 1 · completed Pharmacodynamic Study With FLT-PET/CT in Patients With Prostate/Other Solid Malignancies Treated With High Dose Axitinib · 160 trials list this drug (35 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02700568Phase 2 · completed Axitinib in Metastatic Renal Cell Carcinoma Patients With Favorable Prognostic Factors · 160 trials list this drug (35 active) | — | — | Clear Cell Renal Cell Carcinoma,Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01490866Phase 2 · completed A Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC) · 160 trials list this drug (35 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02814461Phase 1 · completed The Safety and Maximum Tolerated Dose of Axitinib in Combination With Radiotherapy for HCC · 160 trials list this drug (35 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01599754Phase 3 · terminated Adjuvant Axitinib Therapy of Renal Cell Cancer in High Risk Patients · 160 trials list this drug (35 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02857712Phase 2 · completed Axitinib in R/M Salivary Gland Cancers of the Upper Aerodigestive Tract - SGC-AX14 · 160 trials list this drug (35 active) | — | — | Malignant Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00569946Phase 2 · completed Study Of AG-013736 (Axitinib) As Second-Line Treatment In Patients With Metastatic Renal Cell Cancer (mRCC) · 160 trials list this drug (35 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00219557Phase 2 · completed AG-013736 In Combination With Gemcitabine Versus Gemcitabine Alone For Patients With Metastatic Pancreatic Cancer · 160 trials list this drug (35 active) | — | — | Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01562197Phase 2 · completed A Randomized Phase II Clinical Trial on the Efficacy of Axitinib as a Monotherapy or in Combination With Lomustine for the Treatment of Patients With Recurrent Glioblastoma · 160 trials list this drug (35 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03291314Phase 2 · completed Clinical Trial on the Combination of Avelumab and Axitinib for the Treatment of Patients With Recurrent Glioblastoma · 160 trials list this drug (35 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00678392Phase 3 · completed Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell Cancer · 160 trials list this drug (35 active) | — | — | Kidney Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01210495Phase 2 · completed Axitinib For The Treatment Of Advanced Hepatocellular Carcinoma · 160 trials list this drug (35 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01441414Phase 2 · terminated PF-04856884 (CVX-060) In Combination With Axitinib In Patients With Previously Treated Metastatic Renal Cell Carcinoma · 160 trials list this drug (35 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02560012Phase 2 · terminated Personalized Targeted Inhibitors Treatment in Renal Cell Cancer · 160 trials list this drug (35 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01435122Phase 2 · completed A Study of Axitinib in Advanced Carcinoid Tumors · 160 trials list this drug (35 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03275558Phase 1 · withdrawn Clinical Trial of the Use of the Nasal Spray of Patients With Recurrence of Glioblastoma · 160 trials list this drug (35 active) | — | — | Glioblastoma,Glioma,Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01352728Phase 2 · completed Hepatocellular Carcinoma (HCC) Transarterial Chemoembolisation (TACE) +Axitinib · 160 trials list this drug (35 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01174238Phase 2 · completed A Two Arm Trial of Axitinib and Carboplatin/Paclitaxel in Melanoma · 160 trials list this drug (35 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03341845Phase 2 · unknown Neoadjuvant AXITINIB and AVELUMAB for Patients With Localized Clear-cell RCC · 160 trials list this drug (35 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01533948Phase 2 · terminated Axitinib in Treating Patients With Melanoma That is Metastatic or Cannot Be Removed by Surgery · 160 trials list this drug (35 active) | — | — | Melanoma,Uveal Melanoma,Ocular Melanoma with Extraocular Extension | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02164838Phase 1 · completed VEGF Receptor Tyrosine Kinase Inhibitor Axitinib in Children With Recurrent or Refractory Solid Tumors · 160 trials list this drug (35 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01508117Phase 2 · terminated Phase II Axitinib (AG-013736) in Elderly Glioblastoma Multiforme (GBM) Patients · 160 trials list this drug (35 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00835978Phase 2 · completed Axitinib (AG-013736) With Or Without Dose Titration (Increase) In Patients With Kidney Cancer · 160 trials list this drug (35 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01249547Phase 2 · completed Nasopharyngeal Carcinoma (NPC) Axitinib · 160 trials list this drug (35 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01211275Phase 1/Phase 2 · completed Standard Chemotherapy With of Without Axitinib in Malignant Mesothelioma · 160 trials list this drug (35 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01273662Phase 2 · completed Axitinib as Second-line Treatment for Advanced Hepatocellular Carcinoma · 160 trials list this drug (35 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01469546Phase 2 · completed Phase II Trial Evaluating Axitinib In Patients With Unresectable, Recurrent Or Metastatic Head And Neck Cancer · 160 trials list this drug (35 active) | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01483638Phase 2 · terminated Axitinib as Maintenance Treatment in Patients With Metastatic CRC · 160 trials list this drug (35 active) | — | — | Colorectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01486251NA · completed Assessment of Tumor Vascular Effects of Axitinib With Dynamic Ultrasonography in Patients With Metastatic Colorectal Cancer · 160 trials list this drug (35 active) | — | — | Colorectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00768755Phase 1/Phase 2 · completed Evaluation Of The Efficacy Of The Combination Of Axitinib With Pemetrexed And Cisplatin In The Treatment Of Non-Squamous Non-Small Cell Lung Cancer · 160 trials list this drug (35 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01529138Phase 1 · completed Study of Axitinib and Temsirolimus in Solid Tumors · 160 trials list this drug (35 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01473043no longer available Clinical Study With Axitinib In Advanced Kidney Cancer, Who Have Failed First Line Treatment · 160 trials list this drug (35 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00842244Phase 1 · completed Study Of Axitinib In Combination With Cisplatin And Capecitabine In Patients With Advanced Gastric Cancer · 160 trials list this drug (35 active) | — | — | Gastric Neoplasm,Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00389441Phase 2 · completed Study Of AG-013736 In Patients With 131I-Refractory Thyroid Cancer · 160 trials list this drug (35 active) | — | — | Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01255137Phase 2 · completed Phase II Study of Axitinib (AG-013736) With Evaluation of the VEGF-Pathway in Metastatic, Recurrent or Primary Unresectable Adrenocortical Cancer · 160 trials list this drug (35 active) | — | — | Adrenal Cortical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00735904Phase 2 · completed Trial Of AG-013736, Cisplatin, And Gemcitabine For Patients With Squamous Non-Small Cell Lung Cancer · 160 trials list this drug (35 active) | — | — | Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00471146Phase 3 · completed Study Of Gemcitabine Plus AG-013736 Versus Gemcitabine For Advanced Pancreatic Cancer. · 160 trials list this drug (35 active) | — | — | Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00094055Phase 2 · completed Study of the Anti-angiogenesis Agent AG-013736 in Patients With Metastatic Thyroid Cancer · 160 trials list this drug (35 active) | — | — | Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00094094Phase 2 · completed Anti-angiogenesis Agent AG-013736 in Patients With Advanced Non-Small Cell Lung Cancer · 160 trials list this drug (35 active) | — | — | Lung Neoplasm,Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00094107Phase 2 · completed Anti-Angiogenesis Agent AG-013736 In Patients With Metastatic Melanoma · 160 trials list this drug (35 active) | — | — | Skin Neoplasm,Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00447005Phase 1 · completed Study Of AG-013736 (Axitinib) In Patients With Advanced Solid Tumors · 160 trials list this drug (35 active) | — | — | Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00726752Phase 1 · completed A Study In Patients With Advanced Solid Tumor · 160 trials list this drug (35 active) | — | — | Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01469052Phase 1 · completed First In Human, Phase 1 Study of AG013736 In Patients With Solid Tumors · 160 trials list this drug (35 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00949624Phase 1 · completed CP-868,596 And CP-868,596 Plus AG-013736 In Combination With Docetaxel In Advanced Solid Tumors · 160 trials list this drug (35 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |